Red Maple Naturals Melatonin, 3mg Sublingual
Natural health product licensed in Canada
- Other names
- CENTROVIT Melatonin, 3mg Sublingual, Melatonin, 3mg
- Licence holder
- Red Maple Manufacturing Inc.
- NPN or DIN-HM
- 80025404
- Status
- Active licence
- Licence date
- 19 May 2011
- Revision date
- 21 August 2014
- Form
- Comprimé
- Route of administration
- Sublinguale
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Saveur de menthe poivrée, Cellulose microcristalline, Lactose monohydraté, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 Time Unit TBA | minimum: 1 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps relieve the daytime fatigue associated with jet lag. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase syndrome.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking immunosuppressive drugs. Do not use if you are pregnant or breastfeeding. Do not drive or use machinery for 5 hours after taking melatonin.
- Précautions et mises en garde
If symptoms persist continuously for more than 4 weeks (chronic insomnia), consult your health care practitioner. Consult a health care practitioner prior to use if you have a hormonal disorder, diabetes, liver or kidney disease, cerebral palsy, seizure disorders, migraine, depression and/or hypertension or if you are taking blood pressure or sedative/hypnotic medications.
Source
Official Health Canada record, licence 80025404
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging